1,293
Views
37
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study

, , , , , & show all
Pages 1347-1352 | Received 22 Dec 2010, Accepted 09 Jun 2011, Published online: 23 Aug 2011

References

  • DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q 1985;38:302–316.
  • The prevalence of anaemia in women. A tabulation of available information. Geneva, World Health Organization, 1992 (WHO/MCH/MSM/92.2).
  • Zavaleta N, Berlanga R, Lonnerdal B, Brown KH. Prevalence and determinants of iron deficiency anaemia in a representative sample of pregnant women in Lima, Peru. Final report presented to the Pan American Health Organization. Washington DC: Pan American Health Organization; 1993.
  • Toblli JE, Brignoli R. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia/review and meta-analysis. Arzneimittelforschung 2007;57:431–438.
  • Geisser P, Hohl H, Müller A. Clinical effectiveness of three different iron preparations in pregnant women. Schweiz Apoth Ztg 1987;125:393–398.
  • Jacobs P, Fransman D, Coghlan P. Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors. J Clin Apher 1993;8:89–95.
  • Geisser P, Müller A. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes. Arzneimittelforschung 1987;37:100–104.
  • Dresow B, Petersen D, Fischer R, Nielsen P. Non-transferrin-bound iron in plasma following administration of oral iron drugs. Biometals 2008;21:273–276.
  • Tuomainen TP, Nyyssönen K, Porkkala-Sarataho E, Salonen R, Baumgartner JA, Geisser P, Salonen JT. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation. Nutr Res 1999;19:1121–1132.
  • Macdougall IC. Strategies for iron supplementation: Oral versus intravenous. Kidney Int Suppl 1999;69:S61–S66.
  • Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: Establishing a safe dose. Am J Kidney Dis 2001;38:988–991.
  • Jacobs P, Wood L, Bird AR. Erythrocytes: better tolerance of iron polymaltose complex compared with ferrous Sulphate in the treatment of Anaemia. Hematology 2000;5:77–83.
  • Saha L, Pandhi P, Gopalan S, Malhotra S, Saha PK. Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women. MedGenMed 2007;9:1.
  • Hajnaczky K, Demeter J, Székely P, Udvardi E. Our experiences gained in the tolerability study of Maltofer® chewing tablet in the prevention and treatment of iron deficiency anemia in pregnancy. Mahyar Nõorvosok Lapja 2002;65:1–5.
  • Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, Ball MJ, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010;268:286–295.
  • Maltofer® Prescribing Information. Vifor (International) Inc., St Gallen, Switzerland. Last updated September 2004.
  • Geisser P. Safety and efficacy of iron(III)-hydroxide polymaltose complex/a review of over 25 years experience. Arzneimittelforschung 2007;57:439–452.
  • Langstaff RJ, Geisser P, Heil WG, Bowdler MA. Treatment of iron-deficiency anemia: A lower incidence of adverse effects with Ferrum Hausmann than ferrous sulfate. Brit Journal of Clin Research 1993;4:191–198.
  • Kaltwasser JP, Werner E, Niechzial M. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations. Arzneimittelforschung 1987;37:122–129.
  • Geisser P, Philipp E. True iron bioavailability, iron pharmacokinetics and clinically silent side effects. Nutrition, Immunity and Health 2009;1:3–11.
  • Melamed N, Ben-Haroush A, Kaplan B, Yogev Y. Iron supplementation in pregnancy–does the preparation matter? Arch Gynecol Obstet 2007;276:601–604.
  • Schmidt BJ, Morais MB, Fisberg M, Martins A, Machado NL. Therapeutic comparison between ferrous sulfate and trivalent iron, in form of polymaltosed ferric hydroxide complex, in treatment of iron deficiency. Folha Med 1985;90:225–229.
  • Macgregor MW. Maternal anaemia as a factor in prematurity and perinatal mortality. Scottish Medical Journal 1963;8:134.
  • Schorr TO, Hediger ML. Anemia and iron-deficiency anemia: Compilation of data on pregnancy outcome. Am J Clin Nutr 1994;59:492S–501S.
  • Allen LH. Anaemia and iron deficiency: Effects on pregnancy outcome. Am J Clin Nutr 2000;71:1280S–1284S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.